
News|Articles|November 20, 2024
Beyond the Checkbox: How Rethinking Your Cardiac Monitoring Approach Can Dramatically Improve Trial Outcomes
Author(s)AliveCor
AliveCor knows that cardiac safety is critical, with concerns often driving drug withdrawals from trials and the market. Our solutions go beyond compliance to boost regulatory trust, data integrity, and trial success. As the only company offering integrated 6L and 12L ECGs, we provide comprehensive monitoring—onsite and remotely—to meet complex cardiac requirements. Our innovative tools empower sponsors and CROs to control trial data, enabling faster, smarter decisions throughout the research lifecycle.
Trending on Applied Clinical Trials Online
1
Beyond Eligibility: Making Trust and Behavioral Readiness Actionable in Clinical Trial Recruitment
2
ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots
3
AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato
4
ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models
5